Evista
Links shared publicly online about this topic
Tamoxifen, Evista Prevent Breast Cancer
webmd.com — “Updated results from a large breast cancer prevention trial confirm that both the old standby tamoxifen and the osteoporosis drug Evista can substantially cut the risk of developing breast cancer in high-risk postmenopausal women.” View full resource at webmd.com
Most Recently Shared on April 20, 2010 at 8:15 pm By:
Tamoxifen, Evista Prevent Breast Cancer: Updated results from a large breast cancer prevention trial confirm that ... http://bit.ly/csYNyi
iGuard.org - Evista Drug Interactions, Evista Side Effects and Evista Patient Reviews
iguard.org — “iGuard.org - Evista Drug Interactions, Evista Side Effects and Evista Patient Reviews” View full resource at iguard.org
Most Recently Shared on January 4, 2010 at 6:17 pm By:
MediGuard.org Health Organization
Approx 5% of #evista users experiencing hot flashes: http://tinyurl.com/yalwq3t
Long term, tamoxifen stops more cancer than Evista | Reuters
reuters.com — “WASHINGTON (Reuters) - Longer-term results from a head-to-head trial of two drugs that prevent breast cancer shows that tamoxifen works better than rival Eli Lilly and Co's Evista, but with a greater risk” View full resource at reuters.com
Most Recently Shared on April 19, 2010 at 5:05 pm By:
Men For A Cause (TM) Health Organization
Long term, tamoxifen stops more cancer than Evista | Reuters http://shar.es/mvYiw
Long term, tamoxifen stops more cancer than Evista | Reuters
reuters.com — “WASHINGTON (Reuters) - Longer-term results from a head-to-head trial of two drugs that prevent breast cancer shows that tamoxifen works better than rival Eli Lilly and Co's Evista, but with a greater risk” View full resource at reuters.com
Most Recently Shared on April 19, 2010 at 2:48 pm By:
Tamoxifen prevents more breast cancer than Evista http://link.reuters.com/qan48j
Long term, tamoxifen stops more cancer than Evista | Reuters
reuters.com — “WASHINGTON (Reuters) - Longer-term results from a head-to-head trial of two drugs that prevent breast cancer shows that tamoxifen works better than rival Eli Lilly and Co's Evista, but with a greater risk” View full resource at reuters.com
Most Recently Shared on April 19, 2010 at 3:15 pm By:
Tamoxifen prevents more breast cancer than Evista: WASHINGTON (Reuters) - The breast cancer drug tamo... http://bit.ly/b4WvWt #health #news
Long Term, Tamoxifen Stops More Cancer Than Evista - ABC News
abcnews.go.com — “Long Term, Tamoxifen Stops More Cancer Than Evista” View full resource at abcnews.go.com
Most Recently Shared on April 20, 2010 at 3:29 pm By:
Long Term, Tamoxifen Stops More Breast Cancer Than Evista http://bit.ly/c5uBHF
Tamoxifen prevents more breast cancer than Evista - Tom Heston
tomheston.com — “Tamoxifen prevents more breast cancer than Evista - Tom Heston” View full resource at tomheston.com
Most Recently Shared on April 19, 2010 at 3:04 pm By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Tamoxifen prevents more breast cancer than Evista http://bit.ly/a5YZpA
14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010
news-medical.net — “Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.” View full resource at news-medical.net
Most Recently Shared on October 18, 2010 at 1:07 pm By:
14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010: Eli Lilly and Compa... http://bit.ly/9DDdWh
EVISTA improves bone quality as measured by HRpQCT: IIT
news-medical.net — “Interim data from a prospective Investigator Initiated Trial presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the treatment and prevention of osteoporosis in postmenopausal women, improves bone quality as measured by the high-resolution peripheral quantitative computed tomography.” View full resource at news-medical.net
Most Recently Shared on June 28, 2010 at 10:31 am By:
EVISTA improves bone quality as measured by HRpQCT: IIT: Interim data from a prospective Investigator Initiated Tr... http://bit.ly/dvfcCs
Evista satisfaction and usage data | Monitoring more than 3,400 patients | Drug safety information | MediGuard
mediguard.org — “Evista satisfaction and usage data | Monitoring more than 3,400 patients | Drug safety information | MediGuard” View full resource at mediguard.org
Most Recently Shared on April 4, 2011 at 1:17 pm By:
MediGuard.org Health Organization
95% of patients taking #evista use it for Osteoporosis ... http://tinyurl.com/4gdk32z
Phase 3 Trial Shows Investigational Arzoxifene Superior to Evista® (raloxifene HCl) in Women with Osteoporosis http://is.gd/oIji
newsroom.lilly.com — “Phase 3 Trial Shows Investigational Arzoxifene Superior to Evista® (raloxifene HCl) in Women with Osteoporosis http://is.gd/oIji” View full resource at newsroom.lilly.com
Most Recently Shared on March 24, 2009 at 2:18 pm By:
eyeonfda Pharma and Health Lawyer
Phase 3 Trial Shows Investigational Arzoxifene Superior to Evista® (raloxifene HCl) in Women with Osteoporosis http://is.gd/oIji
Study Finds Tamoxifen More Effective Than Lilly's Evista in Breast-Cancer Prevention Many Years After Treatment - WSJ.com
online.wsj.com — “Both drugs cut high-risk women's risk of developing breast cancer, according to a study presented April 19 at the American Association for Cancer Research.” View full resource at online.wsj.com
Most Recently Shared on April 20, 2010 at 12:48 am By:
Men For A Cause (TM) Health Organization
Study Finds Tamoxifen More Effective Than Lilly's Evista in Breast-Cancer Prevention Many Years After Treatment-WSJ.com http://shar.es/mvAtp
Study Finds Tamoxifen More Effective Than Lilly's Evista in Breast-Cancer Prevention Many Years After Treatment - WSJ.com
online.wsj.com — “Both drugs cut high-risk women's risk of developing breast cancer, according to a study presented April 19 at the American Association for Cancer Research.” View full resource at online.wsj.com
Most Recently Shared on April 19, 2010 at 11:50 pm By:
Mona Jauhar Health Professional
WSJ.com - 2 good choices to prevent breast cancer. Older Drug Cuts Breast-Cancer Risk More http://on.wsj.com/9ij6Ea
Study Finds Tamoxifen More Effective Than Lilly's Evista in Breast-Cancer Prevention Many Years After Treatment - WSJ.com
online.wsj.com — “Both drugs cut high-risk women's risk of developing breast cancer, according to a study presented April 19 at the American Association for Cancer Research.” View full resource at online.wsj.com
Most Recently Shared on April 20, 2010 at 1:08 am By:
Older Drug Cuts Cancer Risk More http://on.wsj.com/clwmfv
Raloxifene, Tamoxifen Both Guard Against Breast Cancer - Drugs.com MedNews
drugs.com — “The latest results from a landmark, long-running study find that both tamoxifen and raloxifene help prevent breast cancer in postmenopausal women, although some” View full resource at drugs.com
Most Recently Shared on April 20, 2010 at 3:53 am By:
Raloxifene, Tamoxifen Both Guard Against Breast Cancer - http://bit.ly/ccTCZ4
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
WebMD_News
The leading source for trustworthy and timely health news and information.
-
MediGuard.org
Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.
-
Men For A Cause (TM)
Men For A Cause,is a national nonprofit founded to educate, motivate and empower men in the fight against breast cancer in both women and men internationally
Advertisement
